Direct healthcare costs of patients with type 2 diabetes using long-acting insulin analogues or NPH insulin in a basal insulin-only regimen. [electronic resource]
Producer: 20110120Description: 165-72 p. digitalISSN:- 1878-0210
- Adolescent
- Adult
- Ambulatory Care -- economics
- Chi-Square Distribution
- Child
- Child, Preschool
- Cost-Benefit Analysis
- Denmark
- Diabetes Mellitus, Type 2 -- drug therapy
- Drug Costs
- Female
- General Practice -- economics
- Health Care Costs
- Humans
- Hypoglycemic Agents -- economics
- Infant
- Infant, Newborn
- Insulin -- analogs & derivatives
- Insulin Detemir
- Insulin Glargine
- Insulin, Isophane -- economics
- Insulin, Long-Acting
- Logistic Models
- Male
- Metformin -- economics
- Middle Aged
- Models, Economic
- Odds Ratio
- Outcome and Process Assessment, Health Care -- economics
- Pharmaceutical Services -- economics
- Primary Health Care -- economics
- Propensity Score
- Referral and Consultation -- economics
- Registries
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.